Annual Shareholders Equity
$6.65 M
+$5.60 M+531.61%
December 1, 2023
Summary
- As of February 7, 2025, REVB annual stockholders equity is $6.65 million, with the most recent change of +$5.60 million (+531.61%) on December 1, 2023.
- During the last 3 years, REVB annual shareholders equity has risen by +$3.24 million (+94.86%).
- REVB annual shareholders equity is now at all-time high.
Performance
REVB Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$2.67 M
+$1.53 M+134.44%
September 1, 2024
Summary
- As of February 7, 2025, REVB quarterly stockholders equity is $2.67 million, with the most recent change of +$1.53 million (+134.44%) on September 1, 2024.
- Over the past year, REVB quarterly shareholders equity has increased by +$1.53 million (+134.44%).
- REVB quarterly shareholders equity is now -76.58% below its all-time high of $11.41 million, reached on June 30, 2023.
Performance
REVB Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
REVB Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +531.6% | +134.4% |
| 3 y3 years | +94.9% | +134.4% |
| 5 y5 years | - | +134.4% |
REVB Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +6781.1% | -76.6% | +245.1% |
| 5 y | 5-year | at high | +6781.1% | -76.6% | +245.1% |
| alltime | all time | at high | +6781.1% | -76.6% | +245.1% |
Revelation Biosciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.67 M(+134.4%) |
| Jun 2024 | - | $1.14 M(-88.0%) |
| Mar 2024 | - | $9.47 M(+42.5%) |
| Dec 2023 | $6.65 M(+531.6%) | $6.65 M(-24.6%) |
| Sep 2023 | - | $8.82 M(-22.7%) |
| Jun 2023 | - | $11.41 M(+13.9%) |
| Mar 2023 | - | $10.02 M(+851.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $1.05 M(-1157.8%) | $1.05 M(-52.8%) |
| Sep 2022 | - | $2.23 M(-220.9%) |
| Jun 2022 | - | -$1.84 M(+1771.1%) |
| Mar 2022 | - | -$98.50 K(-1.0%) |
| Dec 2021 | -$99.50 K(-102.9%) | -$99.50 K(-102.7%) |
| Sep 2021 | - | $3.65 M |
| Dec 2020 | $3.41 M | - |
FAQ
- What is Revelation Biosciences annual stockholders equity?
- What is the all time high annual shareholders equity for Revelation Biosciences?
- What is Revelation Biosciences annual shareholders equity year-on-year change?
- What is Revelation Biosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Revelation Biosciences?
- What is Revelation Biosciences quarterly shareholders equity year-on-year change?
What is Revelation Biosciences annual stockholders equity?
The current annual shareholders equity of REVB is $6.65 M
What is the all time high annual shareholders equity for Revelation Biosciences?
Revelation Biosciences all-time high annual stockholders equity is $6.65 M
What is Revelation Biosciences annual shareholders equity year-on-year change?
Over the past year, REVB annual stockholders equity has changed by +$5.60 M (+531.61%)
What is Revelation Biosciences quarterly stockholders equity?
The current quarterly shareholders equity of REVB is $2.67 M
What is the all time high quarterly shareholders equity for Revelation Biosciences?
Revelation Biosciences all-time high quarterly stockholders equity is $11.41 M
What is Revelation Biosciences quarterly shareholders equity year-on-year change?
Over the past year, REVB quarterly stockholders equity has changed by +$1.53 M (+134.44%)